"All she needs is approval from the president to tap into that basket," Henrietta Treyz, director of economic policy research at Veda Partners, said of Ms. Yellen. "There are no other alternatives; there’s no chance of a bill passing Congress." — Henrietta Treyz

By dropping the cost of its Humalog and Humulin insulins, Lilly could sidestep $430 million per year in new Medicaid rebates and make more than $85 million in new annual profit, according to an analysis by Spencer Perlman, the director of healthcare research at Veda Partners. — Spencer Perlman

“The biggest issue here is just the lack of clarity on what’s coming and what it means,” Perlman said in an interview. His analysis draws from government data and reporting from Kaiser Health News. Veda, a Bethesda, Maryland-based policy research firm that doesn’t make stock recommendations, estimated what plans might pay if the proposed rule was finalized without changes. — Spencer Perlman

"There is something deeply ironic about Donald Trump potentially returning to power and implementing the price reductions on something where he went out on a limb for Republicans," Spencer Perlman, director of healthcare research at Veda Partners, an investment advisor, and consultancy firm, told Insider. — Spencer Perlman

Henrietta Treyz, Veda Partners Managing Partner and Director of Economic Policy, discussed the future for Republican Congressman Kevin McCarthy as he makes his bid for House Speaker with Alix Steel and Guy Johnson on "Bloomberg Markets: Americas." (Source: Bloomberg)

“There are some small things on the margins that the administration can do without congress... one of the things specifically would be to institute investment restrictions...” — Henrietta Treyz on Bloomberg Surveillance Podcast

Henrietta Treyz, Veda Partners Director of Economic Policy, says Biden's decision to run for a second term depends on Trump's. “Amongst the Republican party you've got roughly 80% approval for the President's trade agenda... and that's what's driving them”— Henrietta Treyz on Bloomberg Surveillance Podcast

Veda Partners Director of Economic Policy Henrietta Treyz speaks to Bloomberg's Alix Steel and Guy Johnson ahead of the bilateral meeting between President Joe Biden and Prime Minister Boris Johnson on "Bloomberg Markets". (Source: Bloomberg)

"It gives a chance for these hospitals to exist," said Spencer Perlman, director of healthcare research at Veda Partners. "It’s a choice between what you have now and nothing.” Perlman estimates hospitals could receive around $750,000 in additional funding under the program, on average, adding the amount could vary widely depending upon how CMS calculates payments."— Spencer Perlman